Astragalus
Common name: Huang qi
Botanical name: Astragalus membranaceus
© Steven Foster
Astragalus is native to northern China and the elevated regions of the Chinese provinces, Yunnan and Sichuan. The portion of the plant used medicinally is the four- to seven-year-old dried root, collected in the spring. While over 2,000 types of astragalus exist worldwide, the Chinese version has been extensively tested, both chemically and pharmacologically.1
Astragalus has been used in connection with the following conditions (refer to the individual health concern for complete information):
| Science Ratings | Health Concerns |
|---|---|
![]() |
Common cold/sore throat Heart attack Hepatitis Immune function Infection Systemic lupus erythematosus |
Reliable
and relatively consistent scientific data showing a substantial health benefit. Contradictory, insufficient, or preliminary studies
suggesting a health benefit or minimal health benefit. For an herb, supported by traditional use but minimal
or no scientific evidence. For a supplement, little scientific support and/or minimal health
benefit. |
|
Shen Nung, the founder of Chinese herbal medicine, classified astragalus as a superior herb in his classical treatise Shen Nung Pen Tsao Ching (circa A.D. 100). The Chinese name huang qi translates as “yellow leader,” referring to the yellow color of the root and its status as one of the most important tonic herbs. Traditional Chinese Medicine used this herb for night sweats, deficiency of chi (e.g., fatigue, weakness, and loss of appetite), and diarrhea.2
Astragalus contains numerous components, including flavonoids, polysaccharides, triterpene glycosides (e.g., astragalosides I–VII), amino acids, and trace minerals.3 Several preliminary clinical trials in China have suggested that astragalus can benefit immune function and improve survival in some people with cancer.4 Given the poor quality of these trials, it is difficult to know how useful astragalus really was. One Chinese trial also found that astragalus could decrease overactive immune function in people with systemic lupus erythematosus (SLE), an autoimmune disease.5 Further trials are needed, however, to know if astragalus is safe for people with SLE, or any other autoimmune disease.
A double-blind trial found that, in people undergoing dialysis for kidney failure, intravenous astragalus improved one facet of immune function compared to the immune function of untreated people.6 Further study is needed to determine if astragalus can help prevent infections in people undergoing dialysis. Early clinical trials in China suggest astragalus root might also benefit people with chronic viral hepatitis, though it may take one to two months to see results.7
In preliminary trials in China, astragalus has been used after people suffer heart attacks.8 More research is needed to determine whether astragalus is truly beneficial in this situation.
Textbooks on Chinese herbs recommend taking 9–15 grams of the crude herb per day in decoction form.9 A decoction is made by boiling the root in water for a few minutes and then brewing the tea. Alternatively, 3–5 ml of tincture three times per day, are sometimes recommended.
Astragalus has no known side effects when used as recommended.
At the time of writing, there were no well-known drug interactions with astragalus.
Copyright © 2007 Healthnotes, Inc. All rights reserved. www.healthnotes.com
Learn more about Healthnotes, the company.
Learn more about the authors of Healthnotes.
The information presented in Healthnotes is for informational purposes only. It is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. For many of the conditions discussed, treatment with prescription or over the counter medication is also available. Consult your doctor, practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications. Information expires September 2008.